-
Most Popular
Earnings Reports
OGI Stock Earnings: OrganiGram Holdings Beats EPS, Beats Revenue for Q3 2024
OGI stock results show that OrganiGram Holdings beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
PSFE Stock Earnings: Paysafe Beats EPS, Beats Revenue for Q2 2024
PSFE stock results show that Paysafe beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
IHS Stock Earnings: IHS Holding Misses EPS, Beats Revenue for Q2 2024
IHS stock results show that IHS Holding missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
VERO Stock Earnings: Venus Concept Beats EPS, Misses Revenue for Q2 2024
VERO stock results show that Venus Concept beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
HUMA Stock Earnings: Humacyte Misses EPS for Q2 2024
HUMA stock results show that Humacyte missed analyst estimates for earnings per share the second quarter of 2024.
BWEN Stock Earnings: Broadwind Misses Revenue for Q2 2024
BWEN stock results show that Broadwind missed on revenue for the second quarter of 2024.
SRAD Stock Earnings: Sportradar Gr Beats Revenue for Q2 2024
SRAD stock results show that Sportradar Gr beat on revenue for the second quarter of 2024.
PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Misses Revenue for Q2 2024
PRAX stock results show that Praxis Precision Medicine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
INKT Stock Earnings: MiNK Therapeutics Beats EPS for Q2 2024
INKT stock results show that MiNK Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
CIFR Stock Earnings: Cipher Mining Beats EPS, Misses Revenue for Q2 2024
CIFR stock results show that Cipher Mining beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q2 2024
ABOS stock results show that Acumen Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CCLD Stock Earnings: CareCloud Beats EPS, Misses Revenue for Q2 2024
CCLD stock results show that CareCloud beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
MRNS Stock Earnings: Marinus Pharma Misses EPS, Misses Revenue for Q2 2024
MRNS stock results show that Marinus Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
MNMD Stock Earnings: Mind Medicine Misses EPS for Q2 2024
MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the second quarter of 2024.
LOCL Stock Earnings: Local Bounti Misses EPS, Misses Revenue for Q2 2024
LOCL stock results show that Local Bounti missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
MSGS Stock Earnings: Madison Square Garden Beats EPS, Beats Revenue for Q4 2024
MSGS stock results show that Madison Square Garden beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
